Welcome to the 2020 Big4Bio Year-in-Review for the San Francisco Bay Area!
We hope you enjoy looking back on 2020’s top stories, deals, and M&A that went down in SFBay’s research, pharma, and biotech sectors as we head into 2021.
Here’s what you’ll find inside the Year-in-Review 2020 report:
- Facts about the Bay Area’s life sciences industry
- The most-clicked stories of the Big4Bio:SFBay newsletter
- Venture investment figures, top deals, and major M&A
- Our outlook for 2021
- Information from sponsors and partners
This report crunches the numbers that tell the story of Big 4 sectors rising to the occasion; as always, we couldn’t do it without our data partners DealForma and JLL.